Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 22-27

  Dugger, Kari J ^a   Zinn, Kurt R ^b   Weaver, Casey ^c   Bullard, Daniel C ^d   Barnum, Scott R ^a,e  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e The University of Alabama at Birmingham   (United States)

Author keywords

2 integrins; Adhesion molecules; Bioluminescence; Neuroimmunology; T lymphocytes

Indexed keywords

CD2 ANTIGEN; LUCIFERASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLUMINESCENCE; CELL INFILTRATION; CELL PROLIFERATION; CELL SECRETION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; IMAGING SYSTEM; IMMUNOMODULATION; IN VIVO STUDY; LEUKOCYTE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD11A; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; LUCIFERASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 58149234188     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.006     Document Type: Article

References (26)

1. Anderson A.C., Reddy J., Nazareno R., Sobel R.A., Nicholson L.B., and Kuchroo V.K. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173 (2004) 828-834
2. Archelos J.J., Previtali S.C., and Hartung H.P. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 22 (1999) 30-38
3. Azadniv M., Dugger K., Bowers W.J., Weaver C.T., and Crispe I.N. Imaging CD8+ T cell dynamics in vivo using a transgenic luciferase reporter. Int. Immunol. 19 (2007) 1165-1173
4. Barry J., and Kirby B. Novel biologic therapies for psoriasis. Expert Opin. Biol. Ther. 4 (2004) 975-987
5. Bullard D.C., Hu X., Schoeb T.R., Axtell R.C., Raman C., and Barnum S.R. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 6327-6333
6. Bullard D.C., Hu X., Adams J.E., Schoeb T.R., and Barnum S.R. p150,95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. Am. J. Pathol. 170 (2007) 2001-2008
7. Bullard D.C., Hu X., Schoeb T.R., Collins R.G., Beaudet A.L., and Barnum S.R. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 178 (2007) 851-857
8. Cannella B., Cross A.H., and Raine C.S. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46 (1993) 43-55
9. Ding Z.M., Babensee J.E., Simon S.I., Lu H., Perrard J.L., Bullard D.C., Dai X.Y., Bromley S.K., Dustin M.L., Entman M.L., Smith C.W., and Ballantyne C.M. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J. Immunol. 163 (1999) 5029-5038
10. Engelhardt B. Immune cell migration across the blood-brain barrier: molecular mechanisms and therapeutic targeting. Future Neurol. 1 (2006) 47-56
11. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural Transm. 113 (2006) 477-485
12. Gordon E.J., Myers K.J., Dougherty J.P., Rosen H., and Ron Y. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62 (1995) 153-160
13. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., and Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20 (2002) 101-123
14. Laschinger M., Vajkoczy P., and Engelhardt B. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur. J. Immunol. 32 (2002) 3598-3606
15. Ley K., Laudanna C., Cybulsky M.I., and Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 (2007) 678-689
16. Liu L., Graham G.J., Damodaran A., Hu T., Lira S.A., Sasse M., Canasto-Chibuque C., Cook D.N., and Ransohoff R.M. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 17-21
17. Luster A.D., Alon R., and von Andrain U.H. Immune cell migration in inflammation: present and future therapeutics. Nat. Immunol. 6 (2005) 1182-1190
18. Smith A., Stanley P., Jones K., Svensson L., McDowall A., and Hogg N. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol. Rev. 218 (2007) 135-146
19. Sospedra M., and Martin R. Immunology of multiple sclerosis*. Annu. Rev. Immunol. 23 (2005) 683-747
20. Steeber D.A., Venturi G.M., and Tedder T.F. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol. 26 (2005) 9-12
21. Vincenti F., Mendez R., Pescovitz M., Rajagopalan P.R., Wilkinson A.H., Butt K., Laskow D., Slakey D.P., Lorber M.I., Garg J.P., and Garovoy M. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am. J. Transplant 7 (2007) 1770-1777
22. Wang Y., Kai H., Chang F., Shibata K., Tahara-Hanaoka S., Honda S., Shibuya A., and Shibuya K. A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 353 (2007) 857-862
23. Welsh C.T., Rose J.W., Hill K.E., and Townsend J.J. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1 alpha. J. Neuroimmunol. 43 (1993) 161-167
24. Willenborg D.O., Staykova M.A., and Miyasaka M. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity. J. Immunol. 157 (1996) 1973-1980
25. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., and Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin. Nature 356 (1992) 63-66
26. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256